FAT10: Function and Relationship with Cancer

Author(s): Senfeng Xiang, Xuejing Shao, Ji Cao, Bo Yang, Qiaojun He*, Meidan Ying*

Journal Name: Current Molecular Pharmacology

Volume 13 , Issue 3 , 2020

Become EABM
Become Reviewer

Graphical Abstract:


Posttranslational protein modifications are known to be extensively involved in cancer, and a growing number of studies have revealed that the ubiquitin-like modifier FAT10 is directly involved in cancer development. FAT10 was found to be highly upregulated in various cancer types, such as glioma, hepatocellular carcinoma, breast cancer and gastrointestinal cancer. Protein FAT10ylation and interactions with FAT10 lead to the functional change of proteins, including proteasomal degradation, subcellular delocalization and stabilization, eventually having significant effects on cancer cell proliferation, invasion, metastasis and even tumorigenesis. In this review, we summarized the current knowledge on FAT10 and discussed its biological functions in cancer, as well as potential therapeutic strategies based on the FAT10 pathway.

Keywords: FAT10, FAT10ylation, cancer, substrate, ubiquitin-like, post-translational modification

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2020
Page: [182 - 191]
Pages: 10
DOI: 10.2174/1874467212666191113130312
Price: $65

Article Metrics

PDF: 37